Researchers are investigating whether a common cholesterol drug could be repurposed to treat HPV-positive cervical cancer.

Many Americans remain unaware of the cancer risk for both men and women posed by human papillomavirus, a new Ohio State ...

Single-cell analysis revealed the molecular triggers that drive stem cells to become cancerous, which may help inform ...

From penile cancer to oropharyngeal cancer, know the health risks of HPV for men’s health. The expert emphasised on the need ...

HPV isn't just a concern for women — it’s actually more common in men and is driving a rise in dangerous cancers, including ...

Researchers from the University of Chicago Medicine Comprehensive Cancer Center demonstrated the potential of a novel treatment approach including immunotherapy to treat advanced human papillomavirus ...

These vaccines are nearly 100% effective if they're given prior to exposure to the HPV types they cover. And this is why the ...

A recent study published in JAMA Oncology presents promising new data on a treatment regimen beneficial to patients with a subset of head and neck cancer k | Cancer ...

Phase 1/2 trial evaluating the proprietary combination to be run under CRADA with the National Cancer InstituteSecondVersamune®platform candidate ...

A team from University Hospitals Seidman Cancer Center is launching the nation's first-ever clinical trials evaluating the ...

Aprea Therapeutics (APRE) has entered into a Material Transfer Agreement with MD Anderson Cancer Center. Under the agreement, Aprea will supply ...